Novartis Ag (NVS) Dividend Coverage Ratio Growth (3y) (2012 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) Dividend Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn | 1.02% |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn | 15.11% |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn | 41.83% |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | -27.98% |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -20.39% |
| Mar 31, 2025 | -32.93% |
| Mar 31, 2024 | -21.15% |
| Mar 31, 2023 | 1.62% |
| Mar 31, 2022 | 1.75% |
| Mar 31, 2021 | 0.46% |
| Mar 31, 2020 | -8.57% |
| Dec 31, 2019 | -33.95% |
| Mar 31, 2019 | -1.75% |
| Mar 31, 2018 | 42.63% |
| Mar 31, 2017 | 14.46% |
| Dec 31, 2016 | 10.73% |
| Mar 31, 2016 | 7.95% |
| Dec 31, 2015 | 9.04% |
| Mar 31, 2015 | -59.79% |
| Dec 31, 2014 | 15.66% |
| Mar 31, 2014 | 9.01% |
| Dec 31, 2013 | 15.39% |
| Jun 30, 2013 | 70.63% |
| Mar 31, 2013 | 16.63% |